Epidemiological and genetic correlates of Chlamydia trachomatis infection were examined prospectively in 124 male and 361 female adolescents at high risk for human immunodeficiency virus type 1 (HIV-1) infection. Seventy percent of subjects were African American, and 68% had HIV-1 infection. As expected, younger age (!17 years), multiple sex partners (у2), and prior chlamydial infection predicted chlamydial infection during a 6-56-month follow-up period ( , , and , respectively). Human leukocyte antigen (HLA) P p .02 P p .02 P p .03 class II variant DQB1*06 (mostly *0602 and *0603) was associated with chlamydial infection (49% vs. 34%; adjusted relative odds [RO], 1.8; ), as was HLA class I haplotype B*44-Cw*04 (10% vs. 4%; RO, 3.2; P p .005 ). DQB1*06 was found in 9 (75%) of 12 female adolescents with chlamydial pelvic inflammatory P p .009 disease. In contrast, sex, ethnicity, and HIV-1 infection did not predict chlamydial infection. These findings suggest that antigen presentation in adaptive immune responses may serve as a major factor in effective control of C. trachomatis infection. The underlying mechanisms remain to be experimentally elucidated.
icate chlamydial infection in the lower genital tract. However, factors associated with such adaptive immune responses have not been fully elucidated.
Human major histocompatibility complex genes encode cell-surface HLA class I, class II, and accessory (transporter and chaperone) molecules that are essential to antigen presentation to CD8 + cytotoxic T lymphocytes or CD4 + T helper cells. CD8 + T cells are an important immune component in eradication of many intracellular pathogens. HLA class I-restricted cytotoxic T lymphocytes that target C. trachomatis major outer membrane protein have been described [5] . However, experiments using the murine model of C. trachomatis genital infection have failed to confirm a necessary role for CD8 + T cells in resolving infection but provide compelling evidence that CD4 + T cells are absolutely necessary [6, 7] . Immunogenetic studies of human infectious diseases, including HIV-1 infection, hepatitis B and C, and tuberculosis, have revealed that many variants across different HLA specificities may account for resistance or susceptibility to infection and/or disease progression [8, 9] . Host genetic correlates for C. trachomatis infection in humans have begun to emerge from analyses of HLA polymorphisms, primarily in patients with Chlamydia-associated tubal factor infertility, pelvic inflammatory disease, trachoma, and chlamydial hsp60 syndromes [10] [11] [12] [13] [14] [15] . Our findings, which are based on 485 sexually active adolescents, now support the notion that both HLA class I and II gene variants can serve as independent predictors of incident chlamydial infection.
SUBJECTS AND METHODS
Study design and population. HIV-infected and high-risk HIV-uninfected male and female adolescents (13-18 years of age) were enrolled at 15 locations in 13 US cities (4 in the New York/New Jersey area, 3 in the mid-Atlantic region, 6 in the southeast, 1 in Chicago, and 1 in Los Angeles), as described elsewhere for the Reaching for Excellence in Adolescent Care and Health study [16, 17] . Longitudinal data were collected at quarterly intervals from 1996 to 2000 for an initially enrolled group of 550 subjects. Patients with sufficient (6-56 months) follow-up, biological specimens, and other relevant data were selected for analyses of incident C. trachomatis infection, which was tested at baseline and at least once every 6 months by use of ligase chain reaction (LCR) for C. trachomatis on urine, cervicovaginal, and anorectal swab specimens. All Chlamydia-positive persons were given prescriptions for antichlamydial therapy by their health-care providers. The present study conforms to the procedures for informed consent approved by institutional review boards at local and/or sponsoring organizations and human-experimentation guidelines set forth by the US Department of Health and Human Services.
DNA extraction and HLA typing. Methodology for DNA extraction and HLA genotyping have been described elsewhere [18, 19] . In brief, high-molecular-weight genomic DNA was extracted from peripheral blood mononuclear cells by use 6 2 ϫ 10 of the QIAamp Blood Kit following the manufacturer's protocols (Qiagen) and stored at 4ЊC in TE (10 mmol/L Tris-HCl [pH 8.5] , and 2 mmol/L EDTA) buffer. HLA class I genes were typed initially by polymerase chain reaction (PCR) with sequence-specific primers by use of commercially available typing kits (PelFreez Clinical Systems), which defined alleles largely to their 2-digit specificities. Subjects with apparent homozygosity at any class I locus were further defined by sequence-based typing following locus-specific PCR amplification [20] and solid-phase direct sequencing [21] on the ALFexpress automated sequencer (Amersham Pharmacia Biotech). Automated reference-strand conformational analyses (Pel-Freez Clinical Systems) were applied to resolve ambiguities between use of PCR sequence-specific primers and sequence-based typing [22] . Allelic specificities of HLA class II genes DRB1 and DQB1 were resolved to their 4-5-digit molecular level by use of solid-phase DNA sequencing (Amersham Pharmacia Biotech) and PCR with sequence-specific primers, as described elsewhere [19] . Two-locus HLA-B-C and DRB1-DQB1 haplotypes were assigned according to known linkage disequilibria observed in various populations [19, [23] [24] [25] . The 5 DR groups (DR1, DR51, DR52, DR53, and DR8) were also assigned manually on the basis of conserved genetic contents (presence or absence of DRB3, DRB4, and DRB5) within the DRB1 to DRB9 region [26] .
Statistical analyses. Statistical analyses were done with SAS (version 8.5; SAS Institute). Subjects were classified as having chlamydial infection if they tested positive by chlamydial LCR, on a sample obtained from any site, at least once during the study period. The relationship of chlamydial infection to sociodemographic and clinical characteristics or host genetic markers (individual HLA alleles and haplotypes) was assessed by univariate x 2 or Fisher's exact tests. Forward, stepwise multivariable logistic regression models were used to test the independence of genetic and nongenetic correlates of chlamydial infection, and factors with adjusted were considered to P ! .05 be statistically significant.
RESULTS
Characteristics of study participants. Clinical and genetic data were complete for 485 adolescents, predominantly female (74%) and African American (70%), with a mean age of 17 years at baseline (table 1). The median follow-up period was 35 months (range, 6-56 months), with an average ‫ע‬ SD of 6 ‫ע‬ 2 chlamydial LCR tests performed during the study period. Incident (new) chlamydial infection was diagnosed once in 82 patients (17%) and more than once in 117 patients (24%). Of 156 females with incident chlamydial infection diagnosed at least once, 12 (8%) had a clinical diagnosis of pelvic inflammatory disease with an accompanying positive result of chlamydial LCR test at least once. Of 43 males with incident chlamydial infection diagnosed at least once, 1 (2%) had epididymitis with an accompanying positive result of chlamydial LCR test. The majority (329 [68%]) of study participants also had HIV-1 infection, whereas the rest were considered to be at high risk of HIV-1 infection through sexual activity and drug use.
Clear differences in demographics, behaviors, and duration of follow-up were noted among patient groups defined by 0, 1 , or 11 incident chlamydial infection (table 1). Those with chlamydial infection diagnosed у1 times during the study period were more likely to be !17 years old ( ), to be P p .04 African American ( ), to be female ( ), to have P p .008 P p .01 had у2 sex partners during the 3 months before diagnosis of chlamydial infection ( ), and to have had a prior record P p .04 of chlamydial infection ( ). As 2 highly correlated (r P p .002
) measures, the mean number of chlamydial P ! .0001 LCR tests performed and months of follow-up were greater in those with chlamydial infection ( and , re-P p .0001 P p .002 spectively). Duration of follow-up was retained as a covariate in subsequent analyses, because it could be universally applied to individual subjects. In contrast, other evaluated social and clinical characteristics, including age at first sexual activity, status of HIV-1 infection, exposure to highly active antiretroviral therapy, CD4 + T cell count, and use of alcohol, recreational drugs, and birth control pills were similar among patient groups ( ) . P у .11
Distribution of HLA class I and class II alleles and haplotypes, in relation to C. trachomatis infection. Host factors did not differ between patients with 1 positive C. trachomatis test during the study period and those with у2 positive tests (table 1) . Accordingly, the relationship of chlamydial infection to individual genetic (i.e., HLA class I and class II) variants was primarily tested in tables, with the 2 groups of Chla-2 ϫ 2 mydia-positive patients being lumped together as case patients and compared with the Chlamydia-negative group as control subjects. In univariate analyses, HLA variants that were more frequent in case patients than in control subjects included HLA- ) (more-detailed .01 P p .0008 tabulations available on request). For high-resolution alleles within DQB1*06, the most common *0602 and the next most common *0603 had similar associations ( and P p .006 P p , respectively). Other DQB1*06 alleles, such as *0604 and .08 *0605, were too rare to withstand meaningful analyses. In addition, DQB1*06 was present in 9 (75%) of 12 females with at least 1 episode of chlamydial pelvic inflammatory disease and in the only male participant with chlamydial epididymitis. Meanwhile, HLA-B*08 was more common in control subjects than in case patients (10% vs. 5%;
); other individual P p .03 HLA variants present in у5% of patients were similarly distributed between case and control groups.
When HLA-B-Cw and DRB1-DQB1 haplotypes were evaluated in univariate models in those with and those without chlamydial infection, B*08-Cw*07 and DRB1*0301-DQB1*0201 occurred less frequently (B*08-Cw*07, 4% vs. 9%; ; P p .03 DRB1*0301-DQB1*0201, 12% vs. 19%; ), whereas B*44-P p .05 Cw*04 and B*58-Cw*06 occurred more frequently (B*44-Cw*04, 10% vs. 4%;
; B*58-Cw*06, 8% vs. 4%; ). The P p .01 P p .05 B*44-Cw*04 haplotype was present in 2 (17%) of 12 female adolescents with at least 1 episode of chlamydial pelvic inflammatory disease and was not found in the only male participant with chlamydial epididymitis. Increased presence of DRB1*15-DQB1*06 in Chlamydia-infected patients ( ) reflected P p .01 tight linkage disequilibrium between DRB1*15 (mostly *1503 and *1501) and DQB1*06 (mostly *0602). Further association of DQB1*06 alleles (e.g., *0603) with chlamydial infection in the absence of DRB1*15 implied that the DRB1*15-DQB1*06 haplotypic effect was driven by the DQB1*06 alleles rather than DRB1*15. Indeed, DRB1*15 on other haplotypes (e.g., DRB1*15-DQB1*05) were not differentially distributed in the case patients and control subjects.
Relationship of HLA alleles and haplotypes to C. trachomatis infection as defined in multivariate models. Individual HLA and nongenetic factors associated with chlamydial infection in univariate analyses were tested in multivariable logistic regression models (table 2). In the full model, sex, race, HIV-1 status, HLA-A*23 (exclusively *2301), and B*58-Cw*06 did not retain any statistically significant association with chlamydial infection ( ). Other factors, such as age, multiple sex P 1 .05 partners, duration of follow-up, history of prior chlamydial infection, and 3 HLA variants (B*08, B*44-Cw*03, and DQB1*06) showed independent associations with chlamydial infection (P p .001-.04) in the full model; these relationships became clearer in the reduced model.
Alternative analyses of the relationship of HLA alleles and haplotypes to C. trachomatis infection, addressing specific subpopulations. In an alternative univariate analysis of DQB1*06 and B*44-Cw*04, persons with chlamydial infection were more likely to have at least 1 (49%) or both (5%) variants than those without chlamydial infection (34% and 1%, respectively) (P ! .0001). The independence of genetic and nongenetic associations with chlamydial infection was further confirmed in alternative multivariable analyses restricted either to female patients alone or to HIV-1-seronegative patients alone (data not shown). Further analyses of host factors in patients with 1 ( ) versus multiple n p 82 ) studied here and sevn p 340 eral general populations ( ) reported by other inn p 252-977 vestigators [27, 28] . The only exception with increased presence of DRB1*03-DQB1*02 ( ) was not a result of HIV-1 P ! .001 infection (
). For the smaller group of non-African Amer-P 1 .50 ican adolescents ( , including 100 Hispanic and 44 Eun p 145 ropean Americans) in our study, the frequencies of A*23 differed (
) from those seen elsewhere [25, 27, 28] , whereas P р .01 B*08, DQB1*06, and B*44-Cw*04 conformed to the expected frequencies (
, in all pairwise comparisons). HLA class II P 1 .05 haplotypes involving the DQB1*06 group are common in both European Americans and African Americans, but the frequencies of individual alleles (e.g., *0602 and *0603) on these haplotypes differ between the 2 ethnic groups [24] .
DISCUSSION
In a longitudinal study of 485 adolescents, multiple host factors, both genetic and nongenetic, were predictors of C. trachomatis infection. The association of HLA-DQB1*06 (mostly *0602 and *0603) with chlamydial infection, especially upper genital tract infection, suggests that this HLA variant negatively influences adaptive immunity, affecting either eradication of the organism or its pathogenetic consequences. Consistent with our findings, Kinnunen et al. [10] previously reported that DQB1*0602 was significantly more common in patients with tubal factor infertility than in control subjects. Other investigators have also demonstrated associations of HLA-DQ or HLA-DR variants with tubal factor infertility or antibody to chlamydial hsp60 [11, 12, 15] . Further documentation of HLA-B*08 and B*44-Cw*04 as additional factors in C. trachomatis infection could not be immediately related to previous reports based on analyses of chlamydial pelvic inflammatory disease [13] and trachomatous scarring [14] .
Immunologic control of C. trachomatis infection is rather common: ∼15%-20% of untreated patients spontaneously clear their infection [3, 4] . Both in vitro and in vivo studies to date collectively support the notion that adaptive immune responses mediating the control and clearance of acute genital C. trachomatis infection are characterized by a predominance of proinflammatory CD4 + Th1-dependent cytokines (such as interferon-g and tumor necrosis factor-a [TNF-a]) that are believed to suppress chlamydial multiplication, whereas persistence of chlamydial infection is promoted by an immune response characterized by a predominance of anti-inflammatory cytokines (such as interleukin-10) that suppress a proinflammatory cytokine response [29] . The association of the DQB1*06 variant with chlamydial infection in the present study provides further evidence that specific class II HLA alleles influence progression, persistence, or resolution of chlamydial infection. One or more HLA-DQ alleles may regulate the Th1 versus Th2 cytokine responses, either facilitating chlamydial eradication by the host versus evasion of adaptive immune responses with subsequent persistence of infection. Although complications of persisting chlamydial infection, particularly pelvic inflammatory disease, may be attributed to HLA-DQ alleles promoting ineffective immune responses or chronic inflammation, a previous report that antibodies to chlamydial hsp60 in mice are determined in part by genes in the I-A region of the murine major histocompatibility complex (the human orthologue being HLA-DQ) [30] suggests that HLA-DQ alleles may also regulate antibody responses to the chlamydial hsp60.
Although the suspected mechanisms responsible for specific, HLA-restricted antigen presentation and effective immune responses in chlamydial infections have not been fully elucidated, several phenomena in clinical settings other than chlamydial infection may provide some clues to the HLA associations we observed here. For example, the relatively "protective" effect of HLA-B*08 may be attributed to the 8.1 ancestral haplotype, which has been frequently associated with a high immune responder phenotype marked by high-level TNF-a production and increased risk for autoimmune diseases [31] . The alleles of DQB1*06 conferring "risk" for chlamydial infection and/or their corresponding haplotypes have also been reported for cervical intraepithelial neoplasia [32, 33] . Likewise, HLA-B*44 as another unfavorable HLA variant has been seen with a severe form of varicella zoster virus infection (postherpetic neuralgia) [34, 35] , along with recurrent aphthous stomatitis [36] and cytomegalovirus-related retinitis [37] . Collectively, these associations highlight the importance and relevance of HLA alleles and haplotypes to C. trachomatis and other infections.
HIV-1 infection did not correlate with incident chlamydial infection in our analyses. To address whether HIV-1 infection could have confounded the HLA-based associations we observed, we included the covariate for HIV infection in a multivariate model and also performed an alternative analysis restricted to an HIV-negative subpopulation. In neither instance did HIV-1 infection status appear to substantially influence the magnitude of the observed HLA associations, but confirmation of our findings in a larger HIV-negative study population may be warranted. Nonetheless, some of the HLA variants associated with chlamydial infection have been reported to influence the natural history of HIV infection. For example, HLA-B*08 on the A1-B8-DR3 haplotype has been associated with rapid HIV-1 disease progression [38] , whereas B*44 may influence the expression of certain opportunistic infections [39] . However, other HLA variants associated with chlamydial infection do not appear to influence HIV infection or pathogenesis in this cohort [40] . Frequent antiretroviral therapy in HIV-seropositive patients along with the lack of prolonged duration of follow-up did not allow a reliable assessment of potential interactions between HIV and chlamydial infection.
Racial and ethnic differences in the distribution of HLA alleles and haplotypes often complicate association analyses, especially in univariate tests. HLA population frequencies are readily available for major ethnic groups in the United States [25, 27, 28] . For the few markers highlighted in this work, our general-population genetic comparisons did reveal some heterogeneity between the study population and related general populations (table 3) , but all HLA factors (HLA-B*08, DQB1*06, and B*44-Cw*04) independently associated with chlamydial infection matched their expected distribution patterns in African Americans, Hispanic Americans, and European Americans. Therefore, there was no clear indication that population heterogeneity could account for our major findings.
Apart from confirming certain earlier reports of HLA associations with chlamydial syndromes, our analyses were novel in that they emphasized uncomplicated, laboratory-confirmed C. trachomatis infection and were based on a study population that was unique in that African American adolescents made up the majority and many patients also had HIV-1 infection. Demonstration of both class I and II determinants in the same cohort relied heavily on comprehensive HLA genotyping and systematic analyses of HLA alleles and haplotypes. The results should be treated as preliminary, because false-positive associations can arise from significance testing of numerous alleles at a nominal, uncorrected . The major strength of the P ! .05 present study is the simultaneous testing of multiple factors, including sex, race, and HIV-1 infection. Large sample size and considerations of linkage disequilibrium have reduced the likelihood that the independent HLA associations with chlamydial infection resulted from confounding by nongenetic characteristics of the study population.
Highly focused immunologic studies in other cohorts will be valuable in dissecting the full array of immune responses to Chlamydia and its antigens. However, the opportunity to define the multiple immunologic factors governing chlamydial infection will require careful, expensive prospective assembly and follow-up of a cohort-characteristics of our study population. It is unlikely that the HLA-related hypotheses generated from this work can soon be tested in similar cohorts. However, our replication of a previous association of HLA-DQB1*06 with chlamydial infection should encourage experimental verification.
